The global market for Pharmacopoeia Column was valued at US$ 485 million in the year 2024 and is projected to reach a revised size of US$ 833 million by 2031, growing at a CAGR of 8.0% during the forecast period.
A Pharmacopoeia Column refers to a chromatography column that is designed and validated to meet the specifications and standards outlined in a pharmacopoeia. Pharmacopoeias are official publications that provide standards for the quality, purity, and identity of drugs, excipients, and other pharmaceutical substances. These standards are legally recognized and used globally to ensure the safety and efficacy of medicinal products.
North American market for Pharmacopoeia Column is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pharmacopoeia Column is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Pharmacopoeia Column include Agilent, Waters Corporation, Dikma Technologies, Shimadzu, Thermo Fisher Scientific, Danaher, Suzhou Sepax Technologies, Hamilton, Merck, Restek, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmacopoeia Column, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacopoeia Column.
The Pharmacopoeia Column market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmacopoeia Column market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmacopoeia Column manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Agilent
Waters Corporation
Dikma Technologies
Shimadzu
Thermo Fisher Scientific
Danaher
Suzhou Sepax Technologies
Hamilton
Merck
Restek
Tosoh Corporation
Orochem
Hawach Scientific
Welch Materials
MZ-Analysentechnik GmbH
Bio - Rad
Shepard Industries
Idex
Segment by Type
1.7 碌m
2.5 碌m
3.5 碌m
5 碌m
Others
Segment by Application
Pharmaceutical
Biotechnology
Food Safety
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmacopoeia Column manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharmacopoeia Column in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Pharmacopoeia Column 麻豆原创 Overview
1.1 Product Definition
1.2 Pharmacopoeia Column by Type
1.2.1 Global Pharmacopoeia Column 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 1.7 碌m
1.2.3 2.5 碌m
1.2.4 3.5 碌m
1.2.5 5 碌m
1.2.6 Others
1.3 Pharmacopoeia Column by Application
1.3.1 Global Pharmacopoeia Column 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.3.4 Food Safety
1.3.5 Others
1.4 Global Pharmacopoeia Column 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Pharmacopoeia Column Revenue 2020-2031
1.4.2 Global Pharmacopoeia Column Sales 2020-2031
1.4.3 Global Pharmacopoeia Column 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pharmacopoeia Column 麻豆原创 Competition by Manufacturers
2.1 Global Pharmacopoeia Column Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Pharmacopoeia Column Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Pharmacopoeia Column Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pharmacopoeia Column, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharmacopoeia Column, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmacopoeia Column, Product Type & Application
2.7 Global Key Manufacturers of Pharmacopoeia Column, Date of Enter into This Industry
2.8 Global Pharmacopoeia Column 麻豆原创 Competitive Situation and Trends
2.8.1 Global Pharmacopoeia Column 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Pharmacopoeia Column Players 麻豆原创 Share by Revenue
2.8.3 Global Pharmacopoeia Column Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pharmacopoeia Column 麻豆原创 Scenario by Region
3.1 Global Pharmacopoeia Column 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pharmacopoeia Column Sales by Region: 2020-2031
3.2.1 Global Pharmacopoeia Column Sales by Region: 2020-2025
3.2.2 Global Pharmacopoeia Column Sales by Region: 2026-2031
3.3 Global Pharmacopoeia Column Revenue by Region: 2020-2031
3.3.1 Global Pharmacopoeia Column Revenue by Region: 2020-2025
3.3.2 Global Pharmacopoeia Column Revenue by Region: 2026-2031
3.4 North America Pharmacopoeia Column 麻豆原创 Facts & Figures by Country
3.4.1 North America Pharmacopoeia Column 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pharmacopoeia Column Sales by Country (2020-2031)
3.4.3 North America Pharmacopoeia Column Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmacopoeia Column 麻豆原创 Facts & Figures by Country
3.5.1 Europe Pharmacopoeia Column 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pharmacopoeia Column Sales by Country (2020-2031)
3.5.3 Europe Pharmacopoeia Column Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmacopoeia Column 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Pharmacopoeia Column 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pharmacopoeia Column Sales by Region (2020-2031)
3.6.3 Asia Pacific Pharmacopoeia Column Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pharmacopoeia Column 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Pharmacopoeia Column 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pharmacopoeia Column Sales by Country (2020-2031)
3.7.3 Latin America Pharmacopoeia Column Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pharmacopoeia Column 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Pharmacopoeia Column 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pharmacopoeia Column Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pharmacopoeia Column Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmacopoeia Column Sales by Type (2020-2031)
4.1.1 Global Pharmacopoeia Column Sales by Type (2020-2025)
4.1.2 Global Pharmacopoeia Column Sales by Type (2026-2031)
4.1.3 Global Pharmacopoeia Column Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Pharmacopoeia Column Revenue by Type (2020-2031)
4.2.1 Global Pharmacopoeia Column Revenue by Type (2020-2025)
4.2.2 Global Pharmacopoeia Column Revenue by Type (2026-2031)
4.2.3 Global Pharmacopoeia Column Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Pharmacopoeia Column Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pharmacopoeia Column Sales by Application (2020-2031)
5.1.1 Global Pharmacopoeia Column Sales by Application (2020-2025)
5.1.2 Global Pharmacopoeia Column Sales by Application (2026-2031)
5.1.3 Global Pharmacopoeia Column Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Pharmacopoeia Column Revenue by Application (2020-2031)
5.2.1 Global Pharmacopoeia Column Revenue by Application (2020-2025)
5.2.2 Global Pharmacopoeia Column Revenue by Application (2026-2031)
5.2.3 Global Pharmacopoeia Column Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Pharmacopoeia Column Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Agilent
6.1.1 Agilent Company Information
6.1.2 Agilent Description and Business Overview
6.1.3 Agilent Pharmacopoeia Column Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Agilent Pharmacopoeia Column Product Portfolio
6.1.5 Agilent Recent Developments/Updates
6.2 Waters Corporation
6.2.1 Waters Corporation Company Information
6.2.2 Waters Corporation Description and Business Overview
6.2.3 Waters Corporation Pharmacopoeia Column Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Waters Corporation Pharmacopoeia Column Product Portfolio
6.2.5 Waters Corporation Recent Developments/Updates
6.3 Dikma Technologies
6.3.1 Dikma Technologies Company Information
6.3.2 Dikma Technologies Description and Business Overview
6.3.3 Dikma Technologies Pharmacopoeia Column Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Dikma Technologies Pharmacopoeia Column Product Portfolio
6.3.5 Dikma Technologies Recent Developments/Updates
6.4 Shimadzu
6.4.1 Shimadzu Company Information
6.4.2 Shimadzu Description and Business Overview
6.4.3 Shimadzu Pharmacopoeia Column Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Shimadzu Pharmacopoeia Column Product Portfolio
6.4.5 Shimadzu Recent Developments/Updates
6.5 Thermo Fisher Scientific
6.5.1 Thermo Fisher Scientific Company Information
6.5.2 Thermo Fisher Scientific Description and Business Overview
6.5.3 Thermo Fisher Scientific Pharmacopoeia Column Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Thermo Fisher Scientific Pharmacopoeia Column Product Portfolio
6.5.5 Thermo Fisher Scientific Recent Developments/Updates
6.6 Danaher
6.6.1 Danaher Company Information
6.6.2 Danaher Description and Business Overview
6.6.3 Danaher Pharmacopoeia Column Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Danaher Pharmacopoeia Column Product Portfolio
6.6.5 Danaher Recent Developments/Updates
6.7 Suzhou Sepax Technologies
6.7.1 Suzhou Sepax Technologies Company Information
6.7.2 Suzhou Sepax Technologies Description and Business Overview
6.7.3 Suzhou Sepax Technologies Pharmacopoeia Column Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Suzhou Sepax Technologies Pharmacopoeia Column Product Portfolio
6.7.5 Suzhou Sepax Technologies Recent Developments/Updates
6.8 Hamilton
6.8.1 Hamilton Company Information
6.8.2 Hamilton Description and Business Overview
6.8.3 Hamilton Pharmacopoeia Column Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hamilton Pharmacopoeia Column Product Portfolio
6.8.5 Hamilton Recent Developments/Updates
6.9 Merck
6.9.1 Merck Company Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck Pharmacopoeia Column Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Merck Pharmacopoeia Column Product Portfolio
6.9.5 Merck Recent Developments/Updates
6.10 Restek
6.10.1 Restek Company Information
6.10.2 Restek Description and Business Overview
6.10.3 Restek Pharmacopoeia Column Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Restek Pharmacopoeia Column Product Portfolio
6.10.5 Restek Recent Developments/Updates
6.11 Tosoh Corporation
6.11.1 Tosoh Corporation Company Information
6.11.2 Tosoh Corporation Description and Business Overview
6.11.3 Tosoh Corporation Pharmacopoeia Column Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Tosoh Corporation Pharmacopoeia Column Product Portfolio
6.11.5 Tosoh Corporation Recent Developments/Updates
6.12 Orochem
6.12.1 Orochem Company Information
6.12.2 Orochem Description and Business Overview
6.12.3 Orochem Pharmacopoeia Column Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Orochem Pharmacopoeia Column Product Portfolio
6.12.5 Orochem Recent Developments/Updates
6.13 Hawach Scientific
6.13.1 Hawach Scientific Company Information
6.13.2 Hawach Scientific Description and Business Overview
6.13.3 Hawach Scientific Pharmacopoeia Column Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hawach Scientific Pharmacopoeia Column Product Portfolio
6.13.5 Hawach Scientific Recent Developments/Updates
6.14 Welch Materials
6.14.1 Welch Materials Company Information
6.14.2 Welch Materials Description and Business Overview
6.14.3 Welch Materials Pharmacopoeia Column Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Welch Materials Pharmacopoeia Column Product Portfolio
6.14.5 Welch Materials Recent Developments/Updates
6.15 MZ-Analysentechnik GmbH
6.15.1 MZ-Analysentechnik GmbH Company Information
6.15.2 MZ-Analysentechnik GmbH Description and Business Overview
6.15.3 MZ-Analysentechnik GmbH Pharmacopoeia Column Sales, Revenue and Gross Margin (2020-2025)
6.15.4 MZ-Analysentechnik GmbH Pharmacopoeia Column Product Portfolio
6.15.5 MZ-Analysentechnik GmbH Recent Developments/Updates
6.16 Bio - Rad
6.16.1 Bio - Rad Company Information
6.16.2 Bio - Rad Description and Business Overview
6.16.3 Bio - Rad Pharmacopoeia Column Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Bio - Rad Pharmacopoeia Column Product Portfolio
6.16.5 Bio - Rad Recent Developments/Updates
6.17 Shepard Industries
6.17.1 Shepard Industries Company Information
6.17.2 Shepard Industries Description and Business Overview
6.17.3 Shepard Industries Pharmacopoeia Column Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Shepard Industries Pharmacopoeia Column Product Portfolio
6.17.5 Shepard Industries Recent Developments/Updates
6.18 Idex
6.18.1 Idex Company Information
6.18.2 Idex Description and Business Overview
6.18.3 Idex Pharmacopoeia Column Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Idex Pharmacopoeia Column Product Portfolio
6.18.5 Idex Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmacopoeia Column Industry Chain Analysis
7.2 Pharmacopoeia Column Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmacopoeia Column Production Mode & Process Analysis
7.4 Pharmacopoeia Column Sales and 麻豆原创ing
7.4.1 Pharmacopoeia Column Sales Channels
7.4.2 Pharmacopoeia Column Distributors
7.5 Pharmacopoeia Column Customer Analysis
8 Pharmacopoeia Column 麻豆原创 Dynamics
8.1 Pharmacopoeia Column Industry Trends
8.2 Pharmacopoeia Column 麻豆原创 Drivers
8.3 Pharmacopoeia Column 麻豆原创 Challenges
8.4 Pharmacopoeia Column 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Agilent
Waters Corporation
Dikma Technologies
Shimadzu
Thermo Fisher Scientific
Danaher
Suzhou Sepax Technologies
Hamilton
Merck
Restek
Tosoh Corporation
Orochem
Hawach Scientific
Welch Materials
MZ-Analysentechnik GmbH
Bio - Rad
Shepard Industries
Idex
听
听
*If Applicable.
